Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
0.5 EUR
720.78 M EUR
6.38 B EUR
1.28 B
About Terumo Corporation
Sector
Industry
CEO
Hikaru Samejima
Website
Headquarters
Tokyo
Founded
1921
ISIN
JP3546800008
FIGI
BBG000C4GHY5
Terumo Corp. engages in the manufacturing and sale of medical products and equipment. It operates through the following segments: Cardiac and Vascular Company, General Hospital Company, and Blood Management Company. The Cardiac and Vascular Company segment offers services and treatments including cardiac and vascular surgery and interventional therapies performed inside blood vessels. The General Hospital Company segment provides infusion and closed anticancer drug infusion systems, measuring devices system with communication functions, diabetes management, adhesion barrier, and peritoneal dialysis. The Blood Management Company segment offers a combination of apheresis collections, manual and automated whole blood processing, and pathogen reduction. The company was founded by Shibasaburo Kitasato on September 17, 1921 and is headquartered in Tokyo, Japan.
Related stocks
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
Depending on the exchange, the stock ticker may vary. For instance, on FWB exchange Terumo Corporation stocks are traded under the ticker TUO.
We've gathered analysts' opinions on Terumo Corporation future price: according to them, TUO price has a max estimate of 22.50 EUR and a min estimate of 16.15 EUR. Watch TUO chart and read a more detailed Terumo Corporation stock forecast: see what analysts think of Terumo Corporation and suggest that you do with its stocks.
Yes, you can track Terumo Corporation financials in yearly and quarterly reports right on TradingView.
Terumo Corporation is going to release the next earnings report on Nov 12, 2025. Keep track of upcoming events with our Earnings Calendar.
TUO earnings for the last quarter are 0.17 EUR per share, whereas the estimation was 0.14 EUR resulting in a 16.27% surprise. The estimated earnings for the next quarter are 0.14 EUR per share. See more details about Terumo Corporation earnings.
Terumo Corporation revenue for the last quarter amounts to 1.53 B EUR, despite the estimated figure of 1.55 B EUR. In the next quarter, revenue is expected to reach 1.52 B EUR.
TUO net income for the last quarter is 246.48 M EUR, while the quarter before that showed 113.10 M EUR of net income which accounts for 117.92% change. Track more Terumo Corporation financial stats to get the full picture.
Terumo Corporation dividend yield was 0.93% in 2024, and payout ratio reached 32.91%. The year before the numbers were 0.81% and 30.77% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Oct 5, 2025, the company has 30.69 K employees. See our rating of the largest employees — is Terumo Corporation on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Terumo Corporation EBITDA is 1.61 B EUR, and current EBITDA margin is 25.52%. See more stats in Terumo Corporation financial statements.
Like other stocks, TUO shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Terumo Corporation stock right from TradingView charts — choose your broker and connect to your account.